Call him the modern-day Albert Schweitzer – on the front lines, fighting tropical diseases at the source for more than a quarter-century. He has been shot at 15 times in seven different wars, yet has never retreated, and once played a key role in war negotiation settlements between Somalia and Ethiopia.
Schizophrenia. Parkinson’s disease. Attention Deficit HyperactivityDisorder (ADHD). Autism. Alzheimer’s Disease. One thing they all have in common: all are candidates for treatment with a groundbreaking new class of drugs called Ampakines, now in clinical development.
“People [with HIV] can live fairly healthy and normal lives, if treated, but obviously they can’t get treatment if they don’t know they’re HIV positive,” said Larry Siebert, CEO of Chembio Diagnostic Systems, Inc.